MedTrace Logo

Study for IFE4PrEP Intervention on PrEP Uptake by Southern African American Women

NCT05087927 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2024-09-20

No results posted yet for this study

Summary

Purpose: This study is partnering with communities to identify the best ways to provide HIV prevention communication and services for women living in public housing who have been disproportionately affected by HIV but underserved by current HIV prevention programs. The investigators want to work with community members to develop and design the delivery of a program to promote awareness of and access to pre-exposure prophylaxis (PrEP) for HIV prevention among women living in public housing.

Participants: Up to 248 cisgender females who are 18 years of age or older and currently reside in Durham Housing Authority (DHA) housing will be enrolled in this study at UNC.

Procedures (methods): Data collection for this formative study will consist of 4 focus groups of up to 12 women in each focus group living in DHA as well as a survey of 200 women living in DHA.

Conditions

  • HIV Prevention

Interventions

BEHAVIORAL

Gain framing plus demographically targeted photos

Gain framing: Participant feels PrEP puts her in control Participants (majority of whom will be African American) will be shown an image of women of multiple races.

BEHAVIORAL

Loss framing plus demographically targeted photos

Loss framing: Without PrEP, participant feels less in control Participants (majority of whom will be African American) will be shown an image of women of multiple races.

BEHAVIORAL

Gain framing plus not demographically targeted photos

Gain framing: Participant feels PrEP puts her in control Participants (majority of whom will be African American) will be shown an image of an African American woman.

BEHAVIORAL

Loss framing plus not demographically targeted photos

Loss framing: Without PrEP, participant feels less in control Participants (majority of whom will be African American) will be shown an image of an African American woman.

Sponsors & Collaborators

  • Gilead Sciences

    collaborator INDUSTRY

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Carol Golin, MD · UNC-Chapel Hill

  • Lauren Hill, PhD · UNC-Chapel Hill

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-18
Primary Completion
2023-11-28
Completion
2024-03-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05087927 on ClinicalTrials.gov